Showing results (1551-1560 of 1,676) with videos related to

Sort By:
Pageof 168
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2022
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
American Journal of Human Genetics|May 13, 2005
Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) geneCharles E Schwartz, Melanie M May, Nancy J Carpenter, et al.
Seminars in Arthritis and Rheumatism|April 14, 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reportsBrent A Luedders, Brendan J Cope, Daniel Hershberger, et al.
The Lancet. Rheumatology|January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort studyBryant R England, Joshua F Baker, Michael D George, et al.
Science (New York, N.Y.)|January 15, 2011
Genomic signatures predict migration and spawning failure in wild Canadian salmonKristina M Miller, Shaorong Li, Karia H Kaukinen, et al.
Seminars in Arthritis and Rheumatism|August 3, 2010
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesJeffrey R Curtis, Archana Jain, Johan Askling, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Patient Related Outcome Measures|June 19, 2023
Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research NetworksTimothy Beukelman, Millie D Long, Rennie L Rhee, et al.
Cancer Research Communications|July 21, 2023
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate CancersTaraswi Mitra Ghosh, Suman Mazumder, Joshua Davis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2016
Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled TrialChristina Charles-Schoeman, Yuen Yin Lee, Ani Shahbazian, et al.
Pageof 168